Ashina M - Search Results

1

Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.

Ashina M, Kudrow D, Reuter U, Dolezil D, Silberstein S, Tepper SJ, Xue F, Picard H, Zhang F, Wang A, Zhou Y, Hong F, Klatt J, Mikol DD. Ashina M, et al. Cephalalgia. 2019 Dec;39(14):1798-1808. doi: 10.1177/0333102419888222. Epub 2019 Nov 10. Cephalalgia. 2019. PMID: 31707815

2

Nitric oxide synthase inhibition: a new principle in the treatment of migraine attacks.

Lassen LH, Ashina M, Christiansen I, Ulrich V, Grover R, Donaldson J, Olesen J. Lassen LH, et al. Among authors: ashina m. Cephalalgia. 1998 Jan;18(1):27-32. doi: 10.1046/j.1468-2982.1998.1801027.x. Cephalalgia. 1998. PMID: 9601621 Clinical Trial.

3

Possible mechanisms of glyceryl-trinitrate-induced immediate headache in patients with chronic tension-type headache.

Ashina M, Bendtsen L, Jensen R, Sakai F, Olesen J. Ashina M, et al. Cephalalgia. 2000 Dec;20(10):919-24. doi: 10.1046/j.1468-2982.2000.00150.x. Cephalalgia. 2000. PMID: 11304027 Clinical Trial.

4

No increase of calcitonin gene-related peptide in jugular blood during migraine.

Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J. Tvedskov JF, et al. Among authors: ashina m. Ann Neurol. 2005 Oct;58(4):561-8. doi: 10.1002/ana.20605. Ann Neurol. 2005. PMID: 16178016

5

Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers.

Hansen JM, Sitarz J, Birk S, Rahmann AM, Oturai PS, Fahrenkrug J, Olesen J, Ashina M. Hansen JM, et al. Among authors: ashina m. Cephalalgia. 2006 Aug;26(8):992-1003. doi: 10.1111/j.1468-2982.2006.01149.x. Cephalalgia. 2006. PMID: 16886936 Clinical Trial.

6

Magnetic resonance angiography shows dilatation of the middle cerebral artery after infusion of glyceryl trinitrate in healthy volunteers.

Hansen JM, Pedersen Dl, Larsen VA, Sánchez-del-Rio M, Alvarez Linera JR, Olesen J, Ashina M. Hansen JM, et al. Among authors: ashina m. Cephalalgia. 2007 Feb;27(2):118-27. doi: 10.1111/j.1468-2982.2006.01257.x. Cephalalgia. 2007. PMID: 17257231 Clinical Trial.

7

Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine.

Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M. Rahmann A, et al. Among authors: ashina m. Cephalalgia. 2008 Mar;28(3):226-36. doi: 10.1111/j.1468-2982.2007.01497.x. Cephalalgia. 2008. PMID: 18254893 Clinical Trial.

8

Familial hemiplegic migraine type 2 does not share hypersensitivity to nitric oxide with common types of migraine.

Hansen JM, Thomsen LL, Marconi R, Casari G, Olesen J, Ashina M. Hansen JM, et al. Among authors: ashina m. Cephalalgia. 2008 Apr;28(4):367-75. doi: 10.1111/j.1468-2982.2008.01542.x. Epub 2008 Feb 22. Cephalalgia. 2008. PMID: 18294248

9

Familial hemiplegic migraine type 1 shows no hypersensitivity to nitric oxide.

Hansen JM, Thomsen LL, Olesen J, Ashina M. Hansen JM, et al. Among authors: ashina m. Cephalalgia. 2008 May;28(5):496-505. doi: 10.1111/j.1468-2982.2008.01559.x. Epub 2008 Mar 31. Cephalalgia. 2008. PMID: 18384418 Clinical Trial.

10

The cholinomimetic agent carbachol induces headache in healthy subjects.

Schytz HW, Wienecke T, Oturai PS, Olesen J, Ashina M. Schytz HW, et al. Among authors: ashina m. Cephalalgia. 2009 Feb;29(2):258-68. doi: 10.1111/j.1468-2982.2008.01715.x. Cephalalgia. 2009. PMID: 19143771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

456 results

Search Page

Filters